# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
GoodRX shares surged nearly 10% Wednesday afternoon following the announcement of a new direct contracting agreement with Kroge...
GoodRx's Q1 earnings: $0.08 EPS, sales hit $197.88 million, beating expectations fueled by prescription transactions and ph...
GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.
Keybanc analyst Scott Schoenhaus upgrades GoodRx Holdings (NASDAQ:GDRX) from Sector Weight to Overweight and announces $9 pr...